April 14, 2021
Business News

Xencor to Present at the Barclays Global Healthcare Conference

MONROVIA, Calif.–()–Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that Bassil Dahiyat, Ph.D., president and chief executive officer, will participate in a virtual fireside chat at the Barclays Global Healthcare Conference on Wednesday, March 10, 2021 at 2:25 p.m. ET / 11:25 p.m. PT.

A live webcast will be available under “Events & Presentations” in the Investors section of the Company’s website located at www.xencor.com. Following the webcast, a replay will be archived on the website for at least 30 days.

About Xencor, Inc.

Xencor is a clinical-stage…

Click here to view the original article.

Related Posts

You might also like ...

AON Splash Image
GenScript Biotech BV e IES Diagnostics concludono accordo di distribuzione per il kit per anticorpi anti-SARS-CoV-2
Arctos NorthStar Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing April 15, 2021
Riassunto: Velodyne propone le sue avanzate soluzioni lidar al salone dell’automobile Auto Shanghai 2021